Thomas Dörner

43.9k citations
383 papers · 20.2k · 9 hit papers · h-index 76

Impact in

  • Rheumatology top 0.02%
    • Systemic Lupus Erythematosus Research
    • Rheumatoid Arthritis Research and Therapies
  • Immunology top 0.05%
    • T-cell and B-cell Immunology
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses

Papers in

    • Systemic Lupus Erythematosus Research 133
    • Rheumatoid Arthritis Research and Therapies 34
    • T-cell and B-cell Immunology 101
    • Immune Cell Function and Interaction 34
    • Immunodeficiency and Autoimmune Disorders 28

Thomas Dörner

361 papers receiving 19.6k citations

Thomas Dörner's Hit Papers

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II) 2023 · 100 citations
1000+8+17Years since publication2505007501000

Peers

Thomas Dörner
Comparison fields: 5 of 159
  • Rheumatology 6.5k
  • Immunology 9.1k
  • Radiology, Nuclear Medicine and Imaging 3.7k
  • Genetics 1.5k
  • Hematology 1.4k
Replace E. William St. Clair with:
E. William St. Clair United States
Robert P. Kimberly United States
René E. M. Toes Netherlands
Dimitrios T. Boumpas Greece
Mark C. Genovese United States
V. Michael Holers United States
Larry W. Moreland United States
Peter H. Schur United States
Eric L. Matteson United States
Ronald van Vollenhoven Sweden
Thomas Dörner relative to E. William St. Clair United States E. William St. Clair's profile →
Citations per field
00.5×4.1×
E. William St. Clair · 1×
Citations per year

Countries citing papers authored by Thomas Dörner

Since Specialization
Citations

This map shows the geographic impact of Thomas Dörner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Dörner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Dörner more than expected).

Fields of papers citing papers by Thomas Dörner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Dörner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Dörner. The network helps show where Thomas Dörner may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Dörner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Dörner Line = papers co-authored together Thomas Dörner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 383 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
Hit paper breakdown →
20201031
2
Competence and competition: the challenge of becoming a long-lived plasma cell
Hit paper breakdown →
2006781
3
Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus
Hit paper breakdown →
2000520
4
Immunopathogenic mechanisms of systemic autoimmune disease
Hit paper breakdown →
2013439
5
Novel paradigms in systemic lupus erythematosus
Hit paper breakdown →
2019423
6
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
Hit paper breakdown →
2018376
7 2004345
8
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
Hit paper breakdown →
2011327
9 2013326
10 1997310
11 2011296
12 2003290
13 2006261
14 2013255
15 2006251
16 2008231
17 2002228
18 2011221
19 2020219
20 2010217

About Thomas Dörner

Thomas Dörner is a scholar working on Rheumatology, Immunology, Radiology, Nuclear Medicine and Imaging, Physiology and Pathology and Forensic Medicine, having authored 383 papers that have together received 20.2k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (133 papers), T-cell and B-cell Immunology (101 papers), Monoclonal and Polyclonal Antibodies Research (89 papers), Salivary Gland Disorders and Functions (53 papers), Rheumatoid Arthritis Research and Therapies (34 papers), Immune Cell Function and Interaction (34 papers), Chronic Lymphocytic Leukemia Research (30 papers) and Immunodeficiency and Autoimmune Disorders (28 papers). The work is most often cited by research in Rheumatology (6.5k citations), Immunology (9.1k citations), Radiology, Nuclear Medicine and Imaging (3.7k citations), Genetics (1.5k citations) and Hematology (1.4k citations). Thomas Dörner has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Peter E. Lipsky, Andreas Radbruch, Gerd R Burmester, Eva Schrezenmeier, Falk Hiepe, Annett M. Jacobi, Eugen Feist, Henrik E. Mei, Richard Furie and Arne Hansen. Their work appears in journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy, Current Opinion in Rheumatology, Nature Reviews Rheumatology and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact